House of Commons Hansard #113 of the 41st Parliament, 1st Session. (The original version is on Parliament's site.) The word of the day was food.

Topics

Question No. 527
Questions on the Order Paper
Routine Proceedings

3:30 p.m.

Provencher
Manitoba

Conservative

Vic Toews Minister of Public Safety

Mr. Speaker, regarding correspondence--i.e., ministerial dockets--on the subject of international transfers sent to Correctional Service of Canada for response or information, search results indicate that there are over 2,000 entries in CSC’s tracking system and archive. In order to determine which of the letters fit the parameters of the question and in order to categorize the types of letters based on the way the question is organized, a manual review would be required.

Moreover, certain international transfer cases are associated with letter-writing campaigns. An individual case may have upwards of 400 letters associated with it. CSC tracks these campaigns in a different manner. A separate, but similar, manual review would be required in order to incorporate this type of correspondence into the response.

In both cases, a manual review could not be completed within the established timeline.

Question No. 531
Questions on the Order Paper
Routine Proceedings

3:30 p.m.

NDP

Anne Minh-Thu Quach Beauharnois—Salaberry, QC

With regard to Health Canada, Sandoz Canada and the most recent drug shortage: (a) what were the latest inspection reports by Health Canada regarding Sandoz Canada and its Boucherville plant in particular; (b) although the U.S. Food and Drug Administration (FDA) required Sandoz to improve several production lines at its Boucherville plant, did Health Canada consider this plant to be sufficiently safe; (c) what correspondence did Health Canada and the FDA exchange regarding Sandoz or injection drugs between April 1, 2011, and March 12, 2012; (d) did Health Canada receive a notice from the FDA or Sandoz following the FDA’s visit to Sandoz in August of 2011; (e) did Health Canada receive a copy of the letter from the FDA to Sandoz Canada on November 18, 2011; and (f) if so, when did Health Canada receive this letter?

Question No. 531
Questions on the Order Paper
Routine Proceedings

3:30 p.m.

Nunavut
Nunavut

Conservative

Leona Aglukkaq Minister of Health and Minister of the Canadian Northern Economic Development Agency

Mr. Speaker, Health Canada most recently conducted a good manufacturing practice, GMP, inspection from January 24 to February 10, 2012, of Sandoz Canada’s Boucherville plant, where products for sale in Canada are manufactured. No risk to the health and safety of Canadians using health products manufactured at the Sandoz Boucherville facility for sale in Canada was identified by Health Canada. A report was issued to the company on February 20, 2012, with the observations of deficiencies noted in the plant. Most GMP inspections result in the identification of deficiencies. This alone does not automatically result in a non-compliant rating. The deficiencies reported in the February 20, 2012, report were not considered to be critical, and a ‘compliant’ rating was issued. For more information on GMP, members may visit the following link: http://www.hc-sc.gc.ca/dhp-mps/compli-conform/gmp-bpf/index-eng.php.

Information was exchanged between Health Canada and the U.S. Food and Drug Administration, FDA, during the November 2011 and March 2012 period. This information included a heads-up notice that Health Canada received on November 8, 201,1 from the FDA, advising of its intention to issue and post a warning letter to Novartis International AG in Switzerland, Sandoz’s parent company, regarding three facilities: the Boucherville, Quebec, site and two facilities in the United States. The FDA’s heads-up also included a copy of the FDA’s deficiencies noted during its August 2011 inspection, FDA form 483. In response to this heads-up, Health Canada Inspectors inspected Sandoz’s Boucherville facility on November 17, 2011. As part of this visit, it was confirmed that the only Boucherville product that was ultimately mentioned in the FDA warning letter was not sold in Canada. As such, no risk to the health and safety of Canadians was identified from this product. Health Canada did not receive an advance copy of the FDA warning letter.

In March 2012, the FDA confirmed that no further action would be required of Sandoz subject to the remediation plan to be taken at Sandoz U.S.A. sites and the action plan following the fire at the Sandoz Quebec site. It should also be noted that the U.S. FDA inspection report concerning the deficiencies noted by the U.S. FDA on November 8, 2012, has yet to be finalized.

Questions Passed as Orders for Returns
Routine Proceedings

April 30th, 2012 / 3:30 p.m.

Regina—Lumsden—Lake Centre
Saskatchewan

Conservative

Tom Lukiwski Parliamentary Secretary to the Leader of the Government in the House of Commons

Mr. Speaker, if Questions Nos. 528, 529, 530 and 532 could be made orders for returns, these returns would be tabled immediately.

Questions Passed as Orders for Returns
Routine Proceedings

3:30 p.m.

Conservative

The Speaker Andrew Scheer

Is that agreed?

Questions Passed as Orders for Returns
Routine Proceedings

3:30 p.m.

Some hon. members

Agreed.

Question No. 528
Questions Passed as Orders for Returns
Routine Proceedings

3:30 p.m.

NDP

Tyrone Benskin Jeanne-Le Ber, QC

With regard to the Queen's Diamond Jubilee celebrations: (a) what is the total budget for the celebrations, broken down by (i) department, federal institution and crown corporation, (ii) province and territory; (b) which programs provided funding for the celebrations; (c) which programs, funds or projects were subject to funding reductions or were eliminated to allow for the celebrations; (d) for each department, federal institution and crown corporation, what projects and activities were or will be funded, by province and territory; (e) for each department, federal institution and crown corporation, what contracts have been made for projects and activities related to the celebrations, including (i) the date the contract was signed, (ii) the parties to the contract, (iii) the amount of the contract, (iv) a description of the contract; (f) for each department, federal institution and crown corporation, what advertising initiatives related to the celebrations have been initiated or are planned, including the cost of each initiative; and (g) for proposals related to programs or activities associated with the celebrations, (i) which proposals came from the government, (ii) which proposals came from outside the government, (iii) what criteria were used for assessing the proposals and for determining which proposals should receive funding?

(Return tabled)

Question No. 529
Questions Passed as Orders for Returns
Routine Proceedings

3:30 p.m.

NDP

Tyrone Benskin Jeanne-Le Ber, QC

With regard to the commemoration of the 200th anniversary of the War of 1812: (a) what is the total budget for the commemoration, broken down by (i) department, federal institution and crown corporation, (ii) province and territory; (b) which programs provided funding for the commemoration; (c) which programs, funds or projects were subject to funding reductions or were eliminated to allow for the commemoration; (d) for each department, federal institution and crown corporation, what projects and activities were or will be funded, by province and territory; (e) for each department, federal institution and crown corporation, what contracts have been made for projects and activities related to the commemoration, including (i) the date the contract was signed, (ii) the parties to the contract, (iii) the amount of the contract, (iv) a description of the contract; (f) for each department, federal institution and crown corporation, what advertising initiatives related to the commemoration have been initiated or are planned, including the cost of each initiative; and (g) for proposals related to programs or activities associated with the commemoration, (i) which proposals came from the government, (ii) which proposals came from outside the government, (iii) what criteria were used for assessing the proposals and for determining which proposals should receive funding?

(Return tabled)

Question No. 530
Questions Passed as Orders for Returns
Routine Proceedings

3:30 p.m.

NDP

Anne Minh-Thu Quach Beauharnois—Salaberry, QC

With regard to Health Canada and the drug shortage: (a) what are the various plans that have been brought forward since 1990 to address drug shortages; (b) based on which studies is the Minister promoting a voluntary reporting mechanism for the industry to address drug shortages; (c) what are Health Canada’s budgets for inspecting drug manufacturing plants; (d) does Health Canada have a budget for identifying new emergency suppliers in case of a shortage; (e) what are Health Canada’s preferred contingency plans in the event of a sudden production shutdown, such as a bankruptcy or a plant fire; (f) since a few producers are the only ones to produce a given drug, what recourse does Health Canada have if a sudden production shutdown affects a sole producer of a drug; (g) what are the fast-track mechanisms for identifying alternatives for drugs in short supply; (h) in the event of a shortage, how does Health Canada prioritize its shipments of stockpiled products; (i) if there is no surplus inventory and if there is no alternate manufacturer, how does Health Canada determine who has the greatest need for the drugs; (j) what solutions based on what is done in other countries around the world have been considered by Health Canada; and (k) has Health Canada considered a solution based on the Swedish model, where a state-owned corporation produces about 2 percent of the country’s demand for drugs?

(Return tabled)

Question No. 532
Questions Passed as Orders for Returns
Routine Proceedings

3:30 p.m.

NDP

Hoang Mai Brossard—La Prairie, QC

With regard to the review of individuals receiving the Canada Child Tax Benefit (CCTB) and the Universal Child Care Benefit (UCCB): (a) how many people received financial support from these programs for fiscal years 2006-2007 to 2011-2012; (b) how many people received financial support from these programs for fiscal years 2006-2007 to 2011-2012 in the ridings of Hochelaga and Brossard—La Prairie; (c) for the UCCB, (i) what is the number of investigations begun by investigators, broken down by province, (ii) the reasons for these investigations, (iii) the number of files where individuals had amounts owing, (iv) the amounts claimed by the Canada Revenue Agency (CRA); (d) for the CCTB (i) what is the number of investigations begun by investigators, broken down by province, (ii) the reasons for these investigations, (iii) the number of files where individuals had amounts owing, (iv) the amounts claimed by the CRA; (e) for the CCTB, in the ridings of Brossard—La Prairie and Hochelaga, (i) what is the number of investigations begun by investigators, broken down by province, (ii) the reasons for these investigations, (iii) the number of files where individuals had amounts owing, (iv) the amounts claimed by the CRA; (f) for the UCCB, in the ridings of Brossard—La Prairie and Hochelaga, (i) what is the number of investigations begun by investigators, broken down by province, (ii) the reasons for these investigations, (iii) the number of files where individuals had amounts owing, (iv) the amounts claimed by the CRA; (g) what are the reasons that could warrant a review of individuals; and (h) what is the number of reviews begun for each of the reasons warranting a review of individuals?

(Return tabled)

Questions Passed as Orders for Returns
Routine Proceedings

3:30 p.m.

Conservative

Tom Lukiwski Regina—Lumsden—Lake Centre, SK

Mr. Speaker, I ask that the remaining questions be allowed to stand.